clinical trial · NCT00648661
Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg
HealthyEscitalopram Oxalate Tablets 20 mgLexapro® Tablets 20 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan's escitalopram oxalate 20 mg tablets to Forest's Lexapro® 20 mg tablets following a single, oral 20 mg (1 x 20 mg) dose administered under fed conditions.
started
Sep 1, 2004
primary completion
Oct 1, 2004
completion
Oct 1, 2004
last updated
Apr 24, 2024
official title
Single-Dose Food In Vivo Bioequivalence Study of Escitalopram Oxalate Tablets (20 mg; Mylan) to Lexapro® Tablets (20 mg; Forest) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol